Peru vs Tajikistan: Antiretroviral therapy coverage for PMTCT
Peru
91.0%
in 2024
Tajikistan
92.0%
in 2024
Peru rank
25th
Tajikistan rank
22nd
Antiretroviral therapy coverage for PMTCT over time
- Peru
- Tajikistan
How they compare
Tajikistan currently reports 92.0% against 91.0% in Peru, a difference of 1.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Tajikistan ahead.
Peru ranks 25th and Tajikistan ranks 22nd of 84 countries.
Peru has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Peru | Tajikistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 30.3% | 2.1% | 28.2% | Peru |
| 2010s | 67.9% | 47.2% | 20.7% | Peru |
| 2020s | 91.6% | 88.8% | 2.8% | Peru |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Peru or Tajikistan?
- Tajikistan, at 92.0% against 91.0% in Peru as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Peru and Tajikistan?
- 1.0%, with Tajikistan ahead.
- How many years of comparable data are there for Peru and Tajikistan?
- 25 years are reported by both, from 2000 to 2024.
- How do Peru and Tajikistan rank globally for antiretroviral therapy coverage for pmtct?
- Peru ranks 25th and Tajikistan ranks 22nd of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).